EUCR Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.

$9.76  -0.01 (-0.10%)
As of 09/16/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  12/28/2020
Outstanding shares:  13,459,125
Average volume:  11,614
Market cap:   $131,495,651
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   26.33
PS ratio:   0.00
Return on equity:   0.45%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy